Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
International Journal of Cancer
|
November 11, 1992
Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity
S Kanda, A J Cochran, W R Lee, et al.
Oncology
|
January 1, 1993
Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteine
H Takeyama, D S Hoon, R E Saxton, et al.
Cancer
|
July 1, 1977
Expression of histocompatibility (HLA) antigens on tumor cells and normal cells from patients with melanoma
M A Pellegrino, S Ferrone, R A Reisfeld, et al.
Surgery
|
January 1, 1980
Immunologic aspects of unknown primary melanoma
A E Giuliano, H S Moseley, R F Irie, et al.
Journal of Clinical Immunology
|
August 26, 1998
Augmentation of IgM antibody to gp43 tumor-associated antigen peptide by melanoma cell vaccine
T Takahashi, A Conforti, Y Kikumoto, et al.
Cell Biophysics
|
January 1, 1994
Both VH and VL regions contribute to the antigenicity of anti-idiotypic antibody that mimics melanoma associated ganglioside GM3
S Kanda, H Takeyama, Y Kikumoto, et al.
Journal of the National Cancer Institute
|
February 1, 1981
Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen
P C Jones, L L Sze, P Y Liu, et al.
International Journal of Cancer
|
May 15, 1985
Immunogenicity of melanoma-associated gangliosides in cancer patients
T Tai, L D Cahan, T Tsuchida, et al.
International Journal of Cancer
|
July 15, 1987
Ganglioside GM2 on the K562 cell line is recognized as a target structure by human natural killer cells
I Ando, D S Hoon, Y Suzuki, et al.
Biochemistry International
|
July 1, 1992
Ganglioside GM2 levels in human melanoma cells: inverse correlation with lysosomal beta-hexosaminidase A activity
D S Hoon, M M Kaback, J Lim-Steele, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
International Journal of Cancer
|
November 11, 1992
Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity
S Kanda, A J Cochran, W R Lee, et al.
Oncology
|
January 1, 1993
Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteine
H Takeyama, D S Hoon, R E Saxton, et al.
Cancer
|
July 1, 1977
Expression of histocompatibility (HLA) antigens on tumor cells and normal cells from patients with melanoma
M A Pellegrino, S Ferrone, R A Reisfeld, et al.
Surgery
|
January 1, 1980
Immunologic aspects of unknown primary melanoma
A E Giuliano, H S Moseley, R F Irie, et al.
Journal of Clinical Immunology
|
August 26, 1998
Augmentation of IgM antibody to gp43 tumor-associated antigen peptide by melanoma cell vaccine
T Takahashi, A Conforti, Y Kikumoto, et al.
Cell Biophysics
|
January 1, 1994
Both VH and VL regions contribute to the antigenicity of anti-idiotypic antibody that mimics melanoma associated ganglioside GM3
S Kanda, H Takeyama, Y Kikumoto, et al.
Journal of the National Cancer Institute
|
February 1, 1981
Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen
P C Jones, L L Sze, P Y Liu, et al.
International Journal of Cancer
|
May 15, 1985
Immunogenicity of melanoma-associated gangliosides in cancer patients
T Tai, L D Cahan, T Tsuchida, et al.
International Journal of Cancer
|
July 15, 1987
Ganglioside GM2 on the K562 cell line is recognized as a target structure by human natural killer cells
I Ando, D S Hoon, Y Suzuki, et al.
Biochemistry International
|
July 1, 1992
Ganglioside GM2 levels in human melanoma cells: inverse correlation with lysosomal beta-hexosaminidase A activity
D S Hoon, M M Kaback, J Lim-Steele, et al.
Page
of 8